Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.00
Ask: 12.00
Change: 0.00 (0.00%)
Spread: 2.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11.00
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

20 Nov 2017 10:46

RNS Number : 9667W
ADVFN PLC
20 November 2017
 

 

For immediate release

 

20 November 2017 

 

ADVFN PLC

 ("ADVFN" or the "Company")

Corporate Update

 

The Board of ADVFN is pleased to announce that following the success of the MJAC2017 exhibition organised by the Company's US platform, InvestorsHub.com, and launched in Los Angeles during September of this year, ADVFN has formed a new venture: MJAC InvestorsHub International Conferences Limited ("MJAC InvestorsHub"). MJAC InvestorsHub is based in Las Vegas and will develop the MJAC conference and new exhibition opportunities starting with MJAC2018, which will be held in the autumn of 2018 in Las Vegas. USA-based THC Therapeutics, Inc (OTC:THCT) has agreed to take a 50% interest in MJAC InvestorsHub for a cash payment of US$500,000. THC is publicly listed on the US Over-the-Counter market.

 

Clem Chambers CEO of ADVFN said:

 

"After a very pleasing start with the MJAC2017 LA show, MJAC InvestorsHub plans to develop conferences and exhibitions focusing on disruptive technologies including: blockchain, lithium and medical marijuana. Linking up with THC Therapeutics leverages this opportunity with an increased US footprint, finance and enhanced market knowledge."

 

Brandon Romanek CEO of THC Therapeutics, Inc. said:

 

"Having met Clem Chambers, CEO of ADVFN, and spent time with their board of directors as we've worked to establish this partnership, I am very impressed with what they have accomplished and their vision not only for ADVFN, but also our shared vision for MJAC LTD as a leading force in the convention/expo space for these disruptive technologies."

 

 

MJAC2017 was held at the JW Marriot LIVE in Los Angeles in early September 2017 and featured many exhibitors and speakers from the rapidly growing cannabis industry. Further details can be found at https://mjac.io MJAC2017 was a unique environment that allowed industry companies to exhibit their businesses to high net worth investors. As the 'go-to' website for information on MJ Stocks and related investment opportunities, InvestorsHub.com's traffic has been increasing weekly and its forums are actively engaged with insight and opinions from our unique audience.

 

More information on ADVFN can be found at: www.ADVFN.com

 

For further information please contact: 

 

 

ADVFN PLC

Clem Chambers, CEO

 

+44 (0) 207 070 0909

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Felicity Geidt

+44 (0) 207 628 3396

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDBBLFLDFFZFBX
Date   Source Headline
21st Mar 20249:49 amRNSHalf-year Report
9th Feb 202411:19 amRNSNew ADVFN Italia website is launched
12th Jan 20242:00 pmRNSResult of Meeting
28th Dec 20231:10 pmRNSResult of AGM
21st Dec 20237:00 amRNSFinal Results
5th Dec 20234:00 pmRNSNotice of AGM
16th Nov 20231:30 pmRNSHolding(s) in Company
21st Sep 202312:00 pmRNSADFVN connects audience to Doceo content
15th Aug 20236:05 pmRNSCorporate update
9th Jun 20236:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202312:14 pmRNSTrading and corporate update
16th May 20234:33 pmRNSHolding(s) in Company
5th May 20233:06 pmRNSTotal Voting Rights
4th Apr 20237:00 amRNSIssue of Equity
30th Mar 20232:07 pmRNSHolding(s) in Company
30th Mar 20232:05 pmRNSHolding(s) in Company
23rd Mar 20235:02 pmRNSHolding(s) in Company
23rd Mar 20235:01 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
23rd Mar 20233:30 pmRNSDirector/PDMR Shareholding
20th Mar 20236:20 pmRNSAdmission update
14th Mar 202312:05 pmRNSFurther equity issue under the Open Offer
6th Mar 20237:00 amRNSHalf-year Report
6th Feb 202311:53 amRNSDirectorate Change
13th Jan 202311:19 amRNSResult of AGM
11th Jan 20231:15 pmRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.